End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.13 CNY | -1.57% | -4.91% | -13.14% |
May. 20 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
May. 16 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
Business Summary
Number of employees: 8,062
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
36.6
%
| 3,989 | 33.1 % | 3,799 | 36.6 % | -4.76% |
Anti-Infective Drugs
16.7
%
| 2,192 | 18.2 % | 1,731 | 16.7 % | -21.04% |
Cardiovascular Drugs
13.0
%
| 1,734 | 14.4 % | 1,354 | 13.0 % | -21.91% |
Anti-tumor Drugs
8.2
%
| 972 | 8.1 % | 851 | 8.2 % | -12.38% |
Antiparasitic and Veterinary Drugs
8.0
%
| 916 | 7.6 % | 830 | 8.0 % | -9.40% |
Import of Finished Drugs and Promotion of Imported Preparations
6.2
%
| 925 | 7.7 % | 642 | 6.2 % | -30.65% |
Other Drugs
5.5
%
| 558 | 4.6 % | 573 | 5.5 % | +2.65% |
Endocrine Drugs
3.3
%
| 350 | 2.9 % | 343 | 3.3 % | -1.98% |
Other Business
2.1
%
| 328 | 2.7 % | 216 | 2.1 % | -34.32% |
CMO/CDMO/CRO
0.2
%
| 65 | 0.5 % | 26 | 0.2 % | -60.27% |
Other
0.1
%
| 8 | 0.1 % | 9 | 0.1 % | +9.61% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
92.5
%
| 10,910 | 93.2 % | 9,397 | 92.5 % | -13.87% |
Foreign
7.5
%
| 798 | 6.8 % | 760 | 7.5 % | -4.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Qing Yang
CEO | Chief Executive Officer | - | 23-08-30 |
Jia Qiu Du
CHM | Chairman | 50 | 19-05-12 |
Wei Hong Xiao
PSD | President | 56 | 23-10-10 |
Shun Bing Yu
CHM | Chairman | 61 | - |
Ling Jiang
DFI | Director of Finance/CFO | 54 | - |
Xi Fei Shen
SEC | Corporate Secretary | 52 | 17-10-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shun Bing Yu
CHM | Chairman | 61 | - |
Jia Yi Zhao
BRD | Director/Board Member | 64 | 19-05-12 |
Li Rong Yang
BRD | Director/Board Member | 62 | 19-05-12 |
Rong Fu Fei
BRD | Director/Board Member | 39 | 18-01-18 |
Jia Qiu Du
CHM | Chairman | 50 | 19-05-12 |
Hua Li Zhou
BRD | Director/Board Member | 47 | 22-04-18 |
Bo Chao Zheng
BRD | Director/Board Member | 45 | 18-08-14 |
Junli Jin
BRD | Director/Board Member | 44 | 19-05-12 |
Hua Ping Zheng
BRD | Director/Board Member | 37 | 22-04-18 |
Xing Hu Shen
BRD | Director/Board Member | 53 | 23-08-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,243,666,276 | 680,523,114 ( 54.72 %) | 35,792,560 ( 2.878 %) | 54.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
10,191,200 | 0.93% | 11,483,852 $ |
Company contact information
Zhejiang Hisun Pharmaceutical Co., Ltd.
No. 46 Waisha Road Jiaojiang District
318000, Taizhou
+86 576 8882 7890
http://www.hisunpharm.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.14% | 1.34B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- 600267 Stock
- Company Zhejiang Hisun Pharmaceutical Co., Ltd.